← The Wire
TENXNasdaq
TENAX THERAPEUTICS, INC.
Pharmaceutical Preparations · DE · CIK 34956
Develops cardiovascular and pulmonary disease therapeutics, prioritizing pulmonary hypertension treatments like Levosimendan
red 8-K · 90d
$305M
Market cap
$13.50
Last close
+0.5%
1D
+10.2%
5D
649K
Volume
Price · last 39 sessions+1.4%
May 4L $10.54 · H $13.64Jun 29
411
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Company UpdateJun 29, 20268-KShareholder VoteJun 4, 202610-Q10-QMay 12, 20268-KResults of OperationsMay 12, 2026DEFA14ADEFA14AApr 22, 2026DEF 14ADEF 14AApr 22, 20268-KExecutive Change · Company UpdateApr 22, 202610-K10-KMar 10, 20268-KResults of OperationsMar 10, 2026SC 13DSC 13DMar 10, 20268-KExecutive ChangeJan 9, 20268-KCompany UpdateDec 17, 202510-Q10-QNov 12, 20258-KResults of OperationsNov 12, 20258-KCompany UpdateSep 16, 20258-KMaterial AgreementSep 9, 202510-Q10-QAug 13, 20258-KResults of OperationsAug 13, 20258-KBylaw Amendment · Shareholder VoteJun 17, 202510-Q10-QMay 14, 20258-KResults of OperationsMay 14, 2025DEFA14ADEFA14AApr 25, 2025DEF 14ADEF 14AApr 25, 202510-K10-KMar 25, 20258-KResults of OperationsMar 25, 20258-KMaterial Agreement · Equity IssuanceMar 6, 20258-KExecutive ChangeDec 4, 2024SC 13GSC 13GNov 14, 202410-QFORM 10-QNov 13, 20248-KResults of OperationsNov 13, 2024SC 13GTENAX THERAPEUTICS, INC.Nov 12, 20248-KExecutive Change · Shareholder VoteOct 30, 2024DEF 14ADEF 14ASep 27, 2024SC 13GTENX AS OF 08/31/2024Sep 10, 2024SC 13GTHE SCHEDULE 13GAug 19, 2024SC 13GSC 13GAug 19, 2024SC 13GSC 13GAug 15, 2024SC 13GSCHEDULE 13GAug 14, 2024SC 13GJHG PLC OWNS 9.9%Aug 14, 202410-QFORM 10-QAug 13, 20248-KResults of OperationsAug 13, 20248-KReg FD DisclosureAug 12, 20248-KCompany UpdateAug 6, 20248-KExecutive Change · Shareholder VoteJun 13, 2024DEFA14ADEFA14AMay 24, 202410-QFORM 10-QMay 14, 20248-KResults of OperationsMay 14, 2024DEFA14ADEFA 14AApr 26, 2024DEF 14ADEF 14AApr 26, 202410-KFORM 10-KMar 28, 20248-KResults of OperationsMar 28, 20248-KCompany UpdateFeb 23, 2024SC 13GSCHEDULE 13GFeb 20, 20248-KMaterial AgreementFeb 20, 2024SC 13GSC 13GFeb 16, 2024SC 13GSC 13GFeb 15, 20248-KMaterial Agreement · Company UpdateFeb 12, 2024424B4424B4Feb 9, 20248-KCompany UpdateFeb 8, 20248-KCompany UpdateFeb 6, 2024S-1/AFORM S-1/AFeb 2, 2024S-1/AFORM S-1/AFeb 1, 20248-KCompany UpdateJan 19, 20248-KDelisting Notice · Executive ChangeJan 12, 20248-KSecurity-Holder Rights · Bylaw AmendmentJan 5, 2024S-1FORM S-1Dec 1, 20238-KShareholder VoteDec 1, 202310-QFORM 10-QNov 13, 20238-KCompany UpdateNov 13, 2023DEFA14ADEFA 14AOct 27, 2023DEF 14ADEF 14AOct 27, 20238-KDelisting NoticeSep 29, 20238-KBylaw AmendmentAug 15, 202310-QFORM 10-QAug 14, 20238-KCompany UpdateJul 19, 20238-KShareholder VoteJun 13, 2023DEFA14ADEFA14AJun 1, 20238-KCompany UpdateMay 31, 202310-QFORM 10-QMay 15, 2023DEFA14ADEFA14AApr 28, 2023
Insider Activity
◆ Cluster Buy · 4 insidersIn the 90 days to Dec 9, 2025: 4 insiders bought $205K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 9, 2025 | Rich StuartChief Medical Officer | Buy | 2,500 | $10.22 | $26K |
| Dec 8, 2025 | Rich StuartChief Medical Officer | Buy | 2,500 | $10.10 | $25K |
| Dec 4, 2025 | Rich StuartChief Medical Officer | Buy | 2,500 | $9.20 | $23K |
| Dec 3, 2025 | Rich StuartChief Medical Officer | Buy | 1,500 | $9.08 | $14K |
| Dec 2, 2025 | Rich StuartChief Medical Officer | Buy | 1,000 | $9.01 | $9K |
| Nov 20, 2025 | Giordano Christopher ThomasCEO | Buy | 538 | $7.59 | $4K |
| Nov 19, 2025 | Giordano Christopher ThomasCEO | Buy | 455 | $7.51 | $3K |
| Nov 18, 2025 | Almenoff June SherieDirector | Buy | 1,900 | $7.52 | $14K |
| Nov 18, 2025 | Almenoff June SherieDirector | Buy | 1,900 | $7.52 | $14K |
| Nov 18, 2025 | Giordano Christopher ThomasCEO | Buy | 1,612 | $7.75 | $12K |
| Nov 17, 2025 | Mcgauley ThomasInterim CFO | Buy | 5,000 | $7.23 | $36K |
| Nov 17, 2025 | Mcgauley ThomasInterim CFO | Buy | 2,000 | $7.34 | $15K |
| Nov 17, 2025 | Mcgauley ThomasInterim CFO | Buy | 1,000 | $7.35 | $7K |
| Nov 17, 2025 | Almenoff June SherieDirector | Buy | 93 | $7.15 | $665 |
| Nov 17, 2025 | Almenoff June SherieDirector | Buy | 93 | $7.15 | $665 |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance